- Investing Ideas
- /
- Polish Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Polish Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Results
2
1 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
2 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
CLN New | zł27.45 | 3.0% | 87.0% | zł1.5b | zł26.58 | PS7.1x | E73.8% | 0.3% | ||
SLV | zł52.50 | -4.7% | -12.6% | zł963.7m | zł69.23 | PE20.3x | E23.3% | n/a |
Page 1 of 1